Background: The purpose of this pilot study is to assess the efficacy
of cognitive behavior therapy for the treatment of patients with panic
disorder who experience an incomplete response to a trial of pharmaco
therapy. Method: Fifteen consecutive patients with a DSM-III-R diagnos
is of panic disorder referred for further treatment because of an inco
mplete response to pharmacotherapy were treated with 12-weeks of group
cognitive behavior therapy. Patients were evaluated at baseline, endp
oint, and at a mean of 2-months' follow-up to assess changes in panic
attack frequency and global outcome. Eight of the 15 patients were dee
med to have received an inadequate prior trial of medication at baseli
ne, mainly because of a desire to control their symptoms without medic
ation or fear of withdrawal and/or addiction. Seven of the patients we
re symptomatic at baseline despite an adequate prior trial of medicati
on. Results: Overall, patients experienced a significant improvement i
n global function at the end of the cognitive behavior therapy interve
ntion, as well as a decrease in panic attack frequency. Improvement wa
s maintained at follow-up. Conclusion: This study is consistent with a
growing body of evidence that many patients with panic disorder remai
n symptomatic over time and are receiving inadequate pharmacotherapeut
ic treatment. Further, we observed that patients with panic disorder w
ho are incompletely responsive or resistant to pharmacotherapeutic man
agement may benefit from the addition of cognitive behavior therapy.